Back to search
Hemato-Oncologic Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemato-Oncologic Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemato-Oncologic Patients trials you may qualify forAutologous hematopoietic stem cell transplantation(auto-HSCT) plays an important role in treating hematologic malignancies. Mobilization and collection of perip…
Childhood cancer survivors represent a high-risk population that requires risk-based follow-up. Follow-up recommendations have been harmonized. Education and in…
The development of targeted therapies and intensive protocols in oncohaematology has improved the survival of patients with haematological malignancies. The inc…
The aim of this mixed-methods study is to describe both the implementation process and outcomes of the online module Advance Care Plan for (hemato-)oncology pat…
The goals of this observational study are to identify risk factors for ESBL-producing Enterobacterales and carbapenemase-producing Enterobacterales (CPE) coloni…
BACKGROUND/AIM: Secondary forms of diabetes are often understudied and underdiagnosed in children and adolescents with cancer. The objectives of this cohort stu…
The only curative treatment for patients with myelofibrosis (MF) is allogeneic stem cell transplantation (SCT). Treatment with JAK2 inhibitors like pacritinib i…